Market Cap
$18.0M
ACCS
ACCESS Newswire Inc.
$4.71 ▼ -1.46%
Prev close $4.78Market cap$18.0M
12-mo target$12.50 (+165.4%)
Insider Buying Cluster (3 insiders) Services
Snapshot
The big-picture read on ACCS right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
9 funds
Inst. Value
$1.7M
Inst. Activity
1 buys / 1 sells
Insider Activity
$411.5K buy / $0.00 sell
Insider Net $
$411.5K
SEC Reports
3
Price chart 30d -12.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 24, 2026 Insider
Aug 19, 2026 SEC Rein Graeme P. bought 6,000 shares
Director @ $4.95 ($29.7K)
Three ACCS directors, including the CEO, made open-market purchases totaling $109K over a 4-day window at an average pri
CLUSTER — Impact 5/10
Aug 17, 2026 Insider
Rein Graeme P. bought 9,700 shares
Director @ $5.10 ($49.5K)
Aug 14, 2026 Insider
BALBIRNIE BRIAN R bought 10,000 shares
Director, CEO @ $4.95 ($49.5K)
Aug 11, 2026 earnings_calendar
ACCS Q2 2026 Earnings Scheduled — 2026-08-11
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
34,229 shares ($222.5K)
Jun 30, 2026 Inst.
May 29, 2026 SEC BlackRock, Inc. — ADD
15,634 shares ($101.6K)
Two directors, including CEO Brian Balbirnie, made open-market purchases totaling $110K over two days. CEO Balbirnie bou
CLUSTER — Impact 5/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| May 13, 2026 | Lake Street | MAINTAIN | Buy | 45% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Aug 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jul 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Price targets
Where 2 covering analysts think ACCS trades over the next 12 months.
$12.50 +165.4% upside Strong Buy
Current$4.71 Low$12.00 Median$12.50 High$13.00 2 analysts
$12.00$13.00
Analyst rating None as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 2 bullish, 0 bearish, 1 mixed, 0 neutral · avg impact 5.0/10.
BULLISHCLUSTER5/10
Three ACCS directors, including the CEO, made open-market purchases totaling $109K over a 4-day wind
Aug 19, 2026
BULLISHCLUSTER5/10
Two directors, including CEO Brian Balbirnie, made open-market purchases totaling $110K over two day
May 29, 2026
MIXEDCLUSTER5/10
Analysis based on filing metadata only — document content was unavailable. However, cross-filing con
Mar 30, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 11, 2026
earnings_calendar
ACCS Q2 2026 Earnings Scheduled — 2026-08-11
Jul 30, 2026
earnings_calendar
ACCS Q2 2026 Earnings Scheduled — 2026-07-30
May 12, 2026
earnings_calendar
ACCS Q1 2026 Earnings Scheduled — 2026-05-12
Apr 30, 2026
earnings_calendar
ACCS Q1 2026 Earnings Scheduled — 2026-04-30
Mar 19, 2026
earnings_calendar
ACCS Q4 2025 Earnings Scheduled — 2026-03-19
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.12 | $0.12–$0.12 | -40.0% | +4.3% | 1↑ 1↓ | $0.0B | 2 |
| Next Q | $0.14 | $0.13–$0.14 | -20.6% | -3.6% | 1↑ 1↓ | $0.0B | 2 |
| Current FY | $0.45 | $0.44–$0.45 | -21.9% | +1.1% | 1↑ 1↓ | $0.0B | 2 |
| Next FY | $0.77 | $0.77–$0.77 | 73.0% | +24.2% | 1↑ 0↓ | $0.0B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.120 | — |
| 7d ago | $0.115 | +0.005 |
| 30d ago | $0.115 | +0.005 |
| 60d ago | $0.115 | +0.005 |
| 90d ago | $0.115 | +0.005 |
Institutional ownership
Which big funds own ACCS (from quarterly 13F filings) and who is adding or trimming.
9 institutional holders with $1.7M total value (267,395 shares) as of 2026-Q2. Top holders: VANGUARD, GEODE, RENAISSANCE.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 138,594 | $900.9K | 51.8% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 34,229 | $222.5K | 12.8% | TRIM -47.5% |
| RENAISSANCE TECHNOLOGIES LLC | 29,238 | $190.0K | 10.9% | — |
| DIMENSIONAL FUND ADVISORS LP | 22,012 | $143.1K | 8.2% | — |
| VANGUARD FIDUCIARY TRUST CO | 15,960 | $103.7K | 6.0% | — |
| BlackRock, Inc. | 15,634 | $101.6K | 5.8% | ADD +25.1% |
| CITADEL ADVISORS LLC | 10,816 | $70.3K | 4.0% | — |
| Vanguard Global Advisers, LLC | 909 | $5.9K | 0.3% | — |
| MORGAN STANLEY | 3 | $21.00 | 0.0% | ADD +50.0% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | 65,239 | 34,229 | -47.5% | $222.5K |
| BlackRock, Inc. | ADD | 12,494 | 15,634 | +25.1% | $101.6K |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | 31,421 | 65,239 | +107.6% | $578.1K |
| UBS Group AG | ADD | 515 | 658 | +27.8% | $5.8K |
| MORGAN STANLEY | ADD | 2 | 3 | +50.0% | $30.00 |
| UBS Group AG | NEAR_EXIT | 4,755 | 515 | -89.2% | $4.8K |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 27 | 2 | -92.6% | $21.00 |
| UBS Group AG | DOUBLED | 485 | 4,007 | +726.2% | $35.4K |
| MORGAN STANLEY | NEAR_EXIT | 250 | 2 | -99.2% | $18.00 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 16 transactions. Net $411.5K — $411.5K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Rein Graeme P. | Director | BUY | 6,000 | $4.95 | $29.7K |
| Aug 17, 2026 | Rein Graeme P. | Director | BUY | 9,700 | $5.10 | $49.5K |
| Aug 14, 2026 | BALBIRNIE BRIAN R | Director, CEO | BUY | 10,000 | $4.95 | $49.5K |
| Aug 14, 2026 | Pollard Wesley T | Director | BUY | 2,000 | $4.99 | $10.0K |
| Jun 26, 2026 | Staples Joseph | Director | AWARD | 4,386 | — | — |
| Jun 26, 2026 | Rein Graeme P. | Director | AWARD | 4,386 | — | — |
| Jun 26, 2026 | Pollard Wesley T | Director | AWARD | 4,386 | — | — |
| Jun 23, 2026 | BALBIRNIE BRIAN R | Director, CEO | BUY | 1,750 | $6.70 | $11.7K |
| Jun 3, 2026 | Pollard Wesley T | Director | BUY | 1,000 | $6.25 | $6.3K |
| May 27, 2026 | BALBIRNIE BRIAN R | Director, CEO | BUY | 10,000 | $6.46 | $64.6K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ACCS.
Shares short
13,214
Settlement Sep 15, 2026
Change vs prior
-9.5%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈0.3%
Estimate — not % of float
All ACCS filing & press-release reports (3)
- CLUSTER reportAug 19, 2026
- CLUSTER reportMay 29, 2026
- CLUSTER reportMar 30, 2026